Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter.
Acta Pharmacol Sin
; 43(10): 2550-2561, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35217815
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Trimetazidine
Limits:
Animals
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
China